# RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants

> **NCT00497471** · NA · TERMINATED · sponsor: **Hospital Clinic of Barcelona** · enrollment: 832 (actual)

## Conditions studied

- Malaria
- Anemia

## Interventions

- **DRUG:** Deltaprim (3.125 mg pyrimethamine plus 25 mg dapsone)
- **DRUG:** iron (2 mg/kg/daily)

## Key facts

- **NCT ID:** NCT00497471
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1995-02
- **Primary completion:** —
- **Final completion:** 1999-07
- **Target enrollment:** 832 (ACTUAL)
- **Why stopped:** Follow-up end in 1999
- **Last updated:** 2007-07-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00497471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00497471, "RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00497471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*